Clinical ProgressSignificant progress was made with Aethlon's oncology program, including the first treatment of a patient with the company's Hemopurifier without device-related issues.
Financial ManagementAEMD has taken measures to improve operating expense management, extending its cash runway and supporting ongoing clinical activities.
Therapeutic PotentialThe Hemopurifier's potential applications in oncology and infectious diseases show promise for organ transplantation, potentially enhancing the availability of donor kidneys.